Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Beuschlein

Showing results (341-350 of 445) with videos related to

Pageof 45
Sort By:
Nature Genetics|December 9, 2014
Mutations in the deubiquitinase gene USP8 cause Cushing's diseaseMartin Reincke, Silviu Sbiera, Akira Hayakawa, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric studyGuido Di Dalmazi, Caroline Kisker, Davide Calebiro, et al.
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
The <i>ARRplus</i>: a model for renin-dependent and sex-specific aldosterone cut-offs that improves screening for primary aldosteronismSybille Fuld, Jun Yang, Georgiana Constantinescu, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated <i>O</i>-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Ebiomedicine|December 21, 2023
Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotypingLeah T Braun, Andrea Osswald, Stephanie Zopp, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2026
Personalized drug screening and risk assessment in patient-derived gastroenteropancreatic neuroendocrine neoplasmsChristoph J Auernhammer, Katharina Wang, Umberto Maccio, et al.
Pageof 45

Showing results (341-350 of 445) with videos related to

Sort By:
Pageof 45
Nature Genetics|December 9, 2014
Mutations in the deubiquitinase gene USP8 cause Cushing's diseaseMartin Reincke, Silviu Sbiera, Akira Hayakawa, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric studyGuido Di Dalmazi, Caroline Kisker, Davide Calebiro, et al.
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
The <i>ARRplus</i>: a model for renin-dependent and sex-specific aldosterone cut-offs that improves screening for primary aldosteronismSybille Fuld, Jun Yang, Georgiana Constantinescu, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated <i>O</i>-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Ebiomedicine|December 21, 2023
Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotypingLeah T Braun, Andrea Osswald, Stephanie Zopp, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2026
Personalized drug screening and risk assessment in patient-derived gastroenteropancreatic neuroendocrine neoplasmsChristoph J Auernhammer, Katharina Wang, Umberto Maccio, et al.
Pageof 45